476 related articles for article (PubMed ID: 18977174)
21. Hypoxia influences CD40-CD40L mediated inflammation in endothelial and monocytic cells.
Chakrabarti S; Rizvi M; Pathak D; Kirber MT; Freedman JE
Immunol Lett; 2009 Feb; 122(2):170-84. PubMed ID: 19187784
[TBL] [Abstract][Full Text] [Related]
22. The CD40-CD40L system in cardiovascular disease.
Pamukcu B; Lip GY; Snezhitskiy V; Shantsila E
Ann Med; 2011 Aug; 43(5):331-40. PubMed ID: 21244217
[TBL] [Abstract][Full Text] [Related]
23. CD40-CD40 ligand disruption does not prevent hyperoxia-induced injury.
Barazzone Argiroffo C; Donati YR; Boccard J; Rochat AF; Vesin C; Kan CD; Piguet PF
Am J Pathol; 2002 Jan; 160(1):67-71. PubMed ID: 11786400
[TBL] [Abstract][Full Text] [Related]
24. The structural basis of hyper IgM deficiency - CD40L mutations.
Thusberg J; Vihinen M
Protein Eng Des Sel; 2007 Mar; 20(3):133-41. PubMed ID: 17307885
[TBL] [Abstract][Full Text] [Related]
25. [Developments in the study of CD40/ CD40L gene and its polymorphism in atherosclerosis].
Wu T; Guo R; Zhang B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 37(4):413-8. PubMed ID: 22561578
[TBL] [Abstract][Full Text] [Related]
26. Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease.
Howard LM; Miller SD
Autoimmunity; 2004 Aug; 37(5):411-8. PubMed ID: 15621565
[TBL] [Abstract][Full Text] [Related]
27. Blockade by nifedipine of advanced glycation end product-induced CD40-CD40 ligand interaction in endothelial cells.
Yamagishi S; Kikuchi S; Takenaka K; Takeuchi M
Drugs Exp Clin Res; 2005; 31(5-6):221-6. PubMed ID: 16425979
[TBL] [Abstract][Full Text] [Related]
28. From atherosclerosis to acute coronary syndromes: the role of soluble CD40 ligand.
Tousoulis D; Androulakis E; Papageorgiou N; Briasoulis A; Siasos G; Antoniades C; Stefanadis C
Trends Cardiovasc Med; 2010 Jul; 20(5):153-64. PubMed ID: 21742271
[TBL] [Abstract][Full Text] [Related]
29. CD40-CD40L: linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications.
Seijkens T; Kusters P; Engel D; Lutgens E
Diab Vasc Dis Res; 2013 Mar; 10(2):115-22. PubMed ID: 22965071
[TBL] [Abstract][Full Text] [Related]
30. CD40 and CD40L expression in the chicken embryo aorta: possible role in the endothelial-mesenchymal transdifferentiation process.
Arciniegas E; Becerra A; De Sanctis JB; Graterol A; Ramírez R
Anat Rec A Discov Mol Cell Evol Biol; 2003 Oct; 274(2):942-51. PubMed ID: 12973718
[TBL] [Abstract][Full Text] [Related]
31. CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization.
Leroyer AS; Rautou PE; Silvestre JS; Castier Y; Lesèche G; Devue C; Duriez M; Brandes RP; Lutgens E; Tedgui A; Boulanger CM
J Am Coll Cardiol; 2008 Oct; 52(16):1302-11. PubMed ID: 18929241
[TBL] [Abstract][Full Text] [Related]
32. Neutrophil CD40 enhances platelet-mediated inflammation.
Vanichakarn P; Blair P; Wu C; Freedman JE; Chakrabarti S
Thromb Res; 2008; 122(3):346-58. PubMed ID: 18289643
[TBL] [Abstract][Full Text] [Related]
33. Cooperativity in the interaction of synthetic CD40L mimetics with CD40 and its implication in cell signaling.
Wieckowski S; Trouche N; Chaloin O; Guichard G; Fournel S; Hoebeke J
Biochemistry; 2007 Mar; 46(11):3482-93. PubMed ID: 17319699
[TBL] [Abstract][Full Text] [Related]
34. [Platelet-associated CD154: a new interface in haemostasis and in the inflammatory reaction].
Delmas Y; Viallard JF; Villeneuve J; Grosset C; Pasquet JM; Déchanet-Merville J; Nurden P; Pellegrin JL; Rosenbaum J; Combe C; Nurden AT; Ripoche J
Med Sci (Paris); 2005 Oct; 21(10):825-31. PubMed ID: 16197899
[TBL] [Abstract][Full Text] [Related]
35. CD40 ligand-dependent tyrosine nitration of prostacyclin synthase in vivo.
Davis B; Zou MH
Circulation; 2005 Oct; 112(14):2184-92. PubMed ID: 16186418
[TBL] [Abstract][Full Text] [Related]
36. Ileal immune dysregulation in necrotizing enterocolitis: role of CD40/CD40L in the pathogenesis of disease.
Xu J; Treem WR; Roman C; Anderson V; Rubenstein R; Schwarz SM
J Pediatr Gastroenterol Nutr; 2011 Feb; 52(2):140-6. PubMed ID: 21240009
[TBL] [Abstract][Full Text] [Related]
37. CD40 signaling in vascular cells: a key role in atherosclerosis?
Mach F; Schönbeck U; Libby P
Atherosclerosis; 1998 Apr; 137 Suppl():S89-95. PubMed ID: 9694547
[TBL] [Abstract][Full Text] [Related]
38. Macrophage CD40 signaling: a pivotal regulator of disease protection and pathogenesis.
Suttles J; Stout RD
Semin Immunol; 2009 Oct; 21(5):257-64. PubMed ID: 19540774
[TBL] [Abstract][Full Text] [Related]
39. CD40/CD40L system and vascular disease.
Santilli F; Basili S; Ferroni P; Davì G
Intern Emerg Med; 2007 Dec; 2(4):256-68. PubMed ID: 18043876
[TBL] [Abstract][Full Text] [Related]
40. Investigation of gene-gene interactions between CD40 and CD40L in Polish multiple sclerosis patients.
Wagner M; Wisniewski A; Bilinska M; Pokryszko-Dragan A; Cyrul M; Kusnierczyk P; Jasek M
Hum Immunol; 2014 Aug; 75(8):796-801. PubMed ID: 24912008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
